Canandaigua, NY, United States of America

David Parrish Russell

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **David Parrish Russell: Innovator in Genomic Research**

Introduction

David Parrish Russell is a prominent inventor hailing from Canandaigua, NY. With a focus on genomic research, he has contributed significantly to the field of biotechnology, holding two patents that reflect his commitment to advancing medical science.

Latest Patents

His latest patents revolve around newly identified open reading frames within genomic nucleotide sequences. These open reading frames encode polypeptides that are surface-localized, making them pivotal for developing diagnostic methods and immunogenic compositions. The inventions provide means for detecting nucleic acids or polypeptides, along with kits designed for diagnosing infections. Notably, these immunogenic compositions are aimed at preventing or treating bacterial infections and systemic diseases, including conditions such as otitis media.

Career Highlights

Over the course of his career, David Parrish Russell has worked with notable companies including Wyeth and Wyeth Holdings Corporation. His extensive experience in the biopharmaceutical sector has enabled him to translate complex genomic knowledge into practical applications.

Collaborations

Throughout his career, Russell has collaborated with talented professionals such as Robert J Zagursky and Amy Wadhams Masi. These collaborations have allowed for a sharing of ideas and innovation, fostering significant advancements in the field.

Conclusion

In summary, David Parrish Russell stands out as an inventor dedicated to exploring the potential of genomic sequences. Through his patents and collaborations, he has cemented his role as a key player in the quest for innovative solutions to medical challenges. His work continues to inspire future research and development in the biotechnology sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…